Brief: SomaLogic Announces Exclusive Partnership With Illumina To Develop Sequencing-Based Proteomic Solutions
05/01/2022 21:24
Jan 5 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC ANNOUNCES EXCLUSIVE PARTNERSHIP WITH ILLUMINA TO
DEVELOP SEQUENCING-BASED PROTEOMIC SOLUTIONS
* SOMALOGIC INC - FINANCIAL TERMS OF DEAL WERE NOT DISCLOSED
* SOMALOGIC INC - COS WILL DEVELOP CO-EXCLUSIVE, CO-BRANDED,
NEXT-GENERATION SEQUENCING (NGS)-BASED PROTEOMICS PRODUCTS
Source text for Eikon: ID:nGNXRlVfM
Further company coverage: SLGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders